Preparing for First-in-Human Trials
We are currently completing our final preclinical toxicology and formulation studies in preparation for first-in-human trials, targeted for January 2026. This milestone will mark a pivotal shift from bench discovery to clinical development.
Results published to date come from preclinical studies in mice.
Updated